MedTrace Logo

Using mHealth to Aid Opioid Medication Adherence Pilot Study

NCT02017041 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 9

Last updated 2015-02-03

No results posted yet for this study

Summary

The purpose of this study is to evaluate the usability of an interactive smartphone application (app) designed to engage and support patients receiving bup/nal.

Conditions

  • Opioid Dependence

Interventions

DEVICE

Medsignals

MedSignals (www.medsignals.com) is a cellular communicating medication management device designed to improve adherence. It will be used to track when medication is removed from the device at dosing times and deliver audible and visual alerts at dosing times and to relay adherence data securely to patient files. Participants will use this device throughout the 5-week trial. It is a Class I device.

DEVICE

smartphone app

The smartphone app being evaluated in this study is designed to support effective medication management of opioid substitution patients taking buprenorphine/naloxone.

Sponsors & Collaborators

  • Care Team Solutions

    lead INDUSTRY

Principal Investigators

  • Michael Bailey, PhD · Care Team Solutions

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2014-06-30
Completion
2014-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02017041 on ClinicalTrials.gov